Literature DB >> 1282986

Nitric oxide synthase-catalyzed activation of oxygen and reduction of cytochromes: reaction mechanisms and possible physiological implications.

B Mayer1, B Heinzel, P Klatt, M John, K Schmidt, E Böhme.   

Abstract

Purified cerebellar nitric oxide (NO) synthase was found to reduce molecular oxygen to hydrogen peroxide at low concentrations of its substrate L-arginine or its cofactor tetrahydrobiopterin. The characteristics of oxygen reduction appeared to be similar to NO synthesis, as both reactions required reduced nicotinamide adenine dinucleotide phosphate (NADPH), were dependent on Ca2+/calmodulin, and showed optimal reaction rates at slightly acidic conditions. The electron transport from NADPH to molecular oxygen is probably mediated by the reduced flavins, flavine adenine dinucleotide (FAD) and flavin mononucleotide (FMN), which are bound in stoichiometrical amounts to the enzyme. NO synthase shows similarities to cytochrome P450 (cytochrome c) reductase, another FAD- and FMN-containing enzyme, and we found that NO synthase reduced cytochromes and artificial, low molecular mass electron acceptors in a superoxide dismutase-insensitive manner. Thus, NO synthase apparently represents a Ca(2+)-regulated, soluble isoform of cytochrome P450 reductase.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1282986     DOI: 10.1097/00005344-199204002-00016

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  8 in total

1.  Characterization of bovine endothelial nitric oxide synthase as a homodimer with down-regulated uncoupled NADPH oxidase activity: tetrahydrobiopterin binding kinetics and role of haem in dimerization.

Authors:  B M List; B Klösch; C Völker; A C Gorren; W C Sessa; E R Werner; W R Kukovetz; K Schmidt; B Mayer
Journal:  Biochem J       Date:  1997-04-01       Impact factor: 3.857

2.  Autoinhibition of neuronal nitric oxide synthase: distinct effects of reactive nitrogen and oxygen species on enzyme activity.

Authors:  P Kotsonis; A Frey; L G Fröhlich; H Hofmann; A Reif; D A Wink; M Feelisch; H H Schmidt
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

3.  Pterin interactions with distinct reductase activities of NO synthase.

Authors:  M M Pantke; A Reif; J G Valtschanoff; Z Shutenko; A Frey; R J Weinberg; W Pfleiderer; H H Schmidt
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

Review 4.  Clinical pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its metabolites.

Authors:  Satoru Hashimoto; Atsuko Kobayashi
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 5.  In search of a function for tetrahydrobiopterin in the biosynthesis of nitric oxide.

Authors:  B Mayer; E R Werner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

6.  A new approach in the treatment of hypotension in human septic shock by NG-monomethyl-L-arginine, an inhibitor of the nitric oxide synthetase.

Authors:  J Schilling; M Cakmakci; U Bättig; S Geroulanos
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

7.  Prediction of diabetic retinopathy: role of oxidative stress and relevance of apoptotic biomarkers.

Authors:  Mohamed Al-Shabrawey; Sylvia Smith
Journal:  EPMA J       Date:  2010-03-23       Impact factor: 6.543

Review 8.  Impaired vasodilation in the pathogenesis of hypertension: focus on nitric oxide, endothelial-derived hyperpolarizing factors, and prostaglandins.

Authors:  Thomas D Giles; Gary E Sander; Bobby D Nossaman; Philip J Kadowitz
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-04       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.